CureSign
CureSign23About
What does CureSign do?
CureSign is a medical device company developing a solution to personalize cancer treatment for oncologists. Their technology integrates advanced sensors with signal processing and big data tools to enable patient-specific treatment plans. This product, currently in advanced development, has been successfully demonstrated in preclinical studies and is being prepared for commercial use in oncology preclinical trials.
What is CureSign's revenue?
StartupHub estimates CureSign's annual revenue at $698K (range $418K to $1.3M, 67% confidence), based on comparable companies in the sector.
When was CureSign founded?
CureSign was founded in 2016.
What industry does CureSign operate in?
CureSign operates in Healthcare, Sensor, Clinical, Oncology, MedTech, HealthTech.
How many employees does CureSign have?
CureSign has approximately 4 people on record.
What is CureSign's current status?
CureSign's current operating status is: Inactive.
An entrant is a company tagged Oncology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.